Peredo-Escárcega, A. E., Guarner-Lans, V., Pérez-Torres, I., Ortega-Ocampo, S., Carreón-Torres, E., Castrejón-Tellez, V., . . . Rubio-Ruiz, M. E. (2015). The Combination of Resveratrol and Quercetin Attenuates Metabolic Syndrome in Rats by Modifying the Serum Fatty Acid Composition and by Upregulating SIRT 1 and SIRT 2 Expression in White Adipose Tissue. Evid Based Complement Alternat Med.
Stile di citazione ChicagoPeredo-Escárcega, Ana Elena, Verónica Guarner-Lans, Israel Pérez-Torres, Sergio Ortega-Ocampo, Elizabeth Carreón-Torres, Vicente Castrejón-Tellez, Eulises Díaz-Díaz, e María Esther Rubio-Ruiz. "The Combination of Resveratrol and Quercetin Attenuates Metabolic Syndrome in Rats By Modifying the Serum Fatty Acid Composition and By Upregulating SIRT 1 and SIRT 2 Expression in White Adipose Tissue." Evid Based Complement Alternat Med 2015.
Citazione MLAPeredo-Escárcega, Ana Elena, et al. "The Combination of Resveratrol and Quercetin Attenuates Metabolic Syndrome in Rats By Modifying the Serum Fatty Acid Composition and By Upregulating SIRT 1 and SIRT 2 Expression in White Adipose Tissue." Evid Based Complement Alternat Med 2015.